Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic Melanoma

This study has been completed.
Sponsor:
Information provided by:
Genzyme, a Sanofi Company
ClinicalTrials.gov Identifier:
NCT00068211
First received: September 9, 2003
Last updated: June 19, 2008
Last verified: November 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2006
  Estimated Primary Completion Date: No date given